StonvexLoading…
StonvexStonvexStonvexCore line items from CALM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-29 | Q3 2025 2025-08-30 | Annual 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $2.36B | $1.69B | $922.60M | $4.26B |
Operating Income | $409.00M | $373.05M | $249.18M | $1.54B |
Net Income | $352.56M | $302.10M | $199.34M | $1.22B |
EPS (Diluted) | $7.34 | $6.26 | $4.12 | $24.95 |
Total Assets | $3.14B | $3.14B | $3.20B | $3.08B |
Total Liabilities | $432.13M | $446.30M | $494.48M | $518.60M |
Cash & Equivalents | $392.16M | $369.45M | $251.92M | $499.39M |
Free Cash Flow OCF − CapEx | $353.21M | $281.22M | $233.30M | $1.06B |
Shares Outstanding | 48.00M | 48.30M | 48.42M | 48.89M |